Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial is evaluating whether prophylactic levetiracetam improves functional outcomes in the acute phase after spontaneous intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Spontaneous Intracerebral Hemorrhage | Phase 3 | Status: NOT_YET_RECRUITING